In degenerative diseases, SLC7A11-mediated cystine metabolic imbalance leads to NADPH depletion, triggering abnormal cross-linking of cytoskeletal proteins and cell death; whereas in malignant tumors, targeted activation of the disulfidptosis pathway can selectively kill tumor cells. This evidence concerns the gene DNM2 and neurodegenerative disease.